Successful treatment with pazopanib plus PD-1 inhibitor and RAK cells for advanced primary hepatic angiosarcoma: a case report

被引：16

作者：

Qiao, Yu ^{[1
,2
]}

Yang, Jihong ^{[1
,3
]}

Liu, Lili ^{[1
,3
]}

Zeng, Yixin ^{[1
,2
]}

Ma, Jie ^{[4
]}

Jia, Jing ^{[1
]}

Zhang, Li ^{[5
]}

Li, Xiaoguang ^{[6
]}

Wu, Peihong ^{[7
]}

Wang, Wenchao ^{[8
]}

Liu, Dongge ^{[9
]}

Chen, Huan ^{[1
,3
]}

Zhao, Yunbo ^{[1
,2
]}

Xi, Huan ^{[1
]}

Wang, Yao ^{[1
]}

机构：

[1] Beijing Hosp, Natl Ctr Gerontol, Dept Geriatr, Beijing 100730, Peoples R China

[2] Beijing Hosp, Natl Ctr Gerontol, Dept Oncol, Beijing 100730, Peoples R China

[3] Beijing Hosp, Natl Ctr Gerontol, Dept Nephrol, Beijing 100730, Peoples R China

[4] Beijing Hosp, Natl Ctr Gerontol, Biol Treatment Ctr, Beijing 100730, Peoples R China

[5] Zhongshan Univ, Tumor Hosp, Dept Oncol, Guangzhou 510089, Guangdong, Peoples R China

[6] Beijing Hosp, Natl Ctr Gerontol, Minimally Invas Tumor Therapies Ctr, Beijing 100730, Peoples R China

[7] Zhongshan Univ, Tumor Hosp, Ctr Med Image Guided Minimally Invas Therapy, Guangzhou 510089, Guangdong, Peoples R China

[8] Beijing Hosp, Natl Ctr Gerontol, Dept Imaging, Beijing 100730, Peoples R China

[9] Beijing Hosp, Natl Ctr Gerontol, Dept Pathol, Beijing 100730, Peoples R China

来源：

BMC CANCER | 2018年 / 18卷

关键词：

Primary hepatic angiosarcoma; Pazopanib; PD-1; inhibitor; RAK cell; IMMUNOTHERAPY; CARCINOMA; ABLATION; FEATURES; OUTCOMES; LIVER;

D O I：

10.1186/s12885-018-3996-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Primary hepatic angiosarcoma (PHA) is a rare and aggressive solid tumor, with high rates of local recurrence and distant metastasis, and poor prognosis. There are no established treatment guidelines for PHA. Case presentation: A 78-year-old asymptomatic man with PHA that was successfully treated with pazopanib plus PD-1 inhibitor and RetroNectin-activated killer cells (RAK cells). After one month of treatment, there was a clear reduction in the size and number of the liver metastases; and after nearly 15 months, most of the lesions were stable, no new lesions had developed, and the side effect of treatment was minor. Conclusion: Pazopanib, PD-1 inhibitor and RAK cells could serve as a potential option for the treatment of advanced PHA.

引用

页数：5

共 50 条

[1] Successful treatment with pazopanib plus PD-1 inhibitor and RAK cells for advanced primary hepatic angiosarcoma: a case report
Yu Qiao
Jihong Yang
Lili Liu
Yixin Zeng
Jie Ma
Jing Jia
Li Zhang
Xiaoguang Li
Peihong Wu
Wenchao Wang
Dongge Liu
Huan Chen
Yunbo Zhao
Huan Xi
Yao Wang
BMC Cancer, 18
[2] Case Report: Successful treatment of advanced hepatocarcinoma with the PD-1 inhibitor Camrelizumab
Ye, Wenling
Cai, Lihong
Zhang, Minjie
Wu, Yali
Sun, Huina
Wang, Yan-Dong
Xia, Yubing
FRONTIERS IN IMMUNOLOGY, 2023, 14
[3] Successful treatment of advanced pulmonary sarcomatoid carcinoma with the PD-1 inhibitor toripalimab: A case report
Jiao, Yuyan
Liu, Ming
Luo, Ningning
Guo, Hao
Li, Jianzhe
ORAL ONCOLOGY, 2021, 112
[4] Successful Treatment of Metastatic Gallbladder Carcinoma with PD-L1 Expression by the Combination of PD-1 Inhibitor Plus Bevacizumab with Chemotherapy: A Case Report
Guo, Lihong
Zhang, Jie
Liu, Xueqin
Liu, Haocong
Zhang, Yamin
Liu, Jinpeng
ONCOTARGETS AND THERAPY, 2022, 15 : 629 - 636
[5] Successful Treatment of Metastatic Primary Cutaneous Adnexal Carcinoma With a PD-1 Inhibitor
Patel, Janmesh D.
Pozorski, Vincent J.
Tavberidze, Nika
Buehler, Darya G.
Huang, Wei
Bennett, Daniel D.
Ma, Vincent T.
JOURNAL OF IMMUNOTHERAPY, 2024, 47 (08) : 323 - 327
[6] Use of PD-1 inhibitor tislelizumab in the treatment of advanced pulmonary sarcomatoid carcinoma: A case report
Xu, Li
Tao, Ning-ning
Liang, Bin
Li, Dao-wei
Li, Huai-chen
Su, Li-li
THORACIC CANCER, 2022, 13 (03) : 502 - 505
[7] Successful liver transplantation with ctDNA clearance after PD-1 inhibitor plus FOLFOX-HAIC treatment in HCC: A case report
Zhao, Yuanyuan
Chen, Dong
Yang, Bo
Xu, Jing
Wang, Lu
Huang, Guobin
Wei, Lai
Chen, Zhishui
ONCOLOGY LETTERS, 2024, 27 (02)
[8] Successful surgical treatment for primary cardiac angiosarcoma: a case report
Suehiro, Yasuo
Kajiyama, Tetsuya
Satoh, Ayaka
Uemura, Hisashi
Nakagawa, Takaya
Matsue, Hajime
Satoh, Hisashi
Takase, Naoto
Doi, Hiroshi
GENERAL THORACIC AND CARDIOVASCULAR SURGERY CASES, 2023, 2 (01):
[9] Treatment of Multiple Primary Malignancies With PD-1 Inhibitor Camrelizumab: A Case Report and Brief Literature Review
Wan, Yuchen
Wang, Zhixue
Yang, Ning
Liu, Fenye
FRONTIERS IN ONCOLOGY, 2022, 12
[10] Successful treatment of refractory leiomyosarcoma with the PD-1 inhibitor nivolumab
Heine, A.
Kristiansen, G.
Schild, H. H.
Brossart, P.
ANNALS OF ONCOLOGY, 2016, 27 (09) : 1813 - 1814

← 1 2 3 4 5 →